Introduction
PP1201/RECS1 has been identified as a gene responsive to centrifugal force and shear stress (RECS) [1] . PP1201-deficient mice show no phenotypic abnormalities, but aged knockout mice are prone to cystic medial degeneration (CMD), a pathological condition encountered in aortic aneurysms [2, 3] . These animals display abnormal aortic media with large CMD foci manifested by absence of smooth muscle cells and by the accumulation of basophilic ground substance referred as mucoid degeneration. The aneurysms observed in PP1201-deficient mice are noninflammatory as the loss of cells in CMD lesions is not associated with infiltration of T lymphocytes or macrophages [2] . Whereas these studies propose a protective role for PP1201 in vascular homeostasis, they do not address signaling pathways modulated by PP1201 and whether increased levels of PP1201 are obligatory for such a function.
PP1201 encodes for a protein with seven transmembrane domains that has been reported to localize to endosomal and lysosomal membranes. Detailed phylogenetic analysis indicates that PP1201 shares lineage with Lifeguard (LFG) and in vertebrates both these genes are derived from two rounds of duplications of a single ancestor [4] . Expression of LFG is developmentally upregulated in the sciatic nerve [5, 6] and it is known to function as an anti-apoptotic protein by interacting directly with death receptor, Fas and protects neuronal cells against FasL-induced cell death [5] [6] [7] [8] . Whereas the association of LFG with Fas is essential for its inhibitory function, this interaction had no effect on Fas trafficking to the plasma membrane [5] . Notwithstanding the similarities between LFG and PP1201, no role for PP1201 in apoptosis has ever been reported. Given that PP1201 levels increase in response to shear stress in vascular cells and aged PP1201-deficient aged mice are prone to the development of aortic aneurysms, we hypothesized that upergulation of PP1201 offer resistance against cell death.
Apoptosis is a conserved programmed cell death process triggered in many cell types by exposure to a variety of stimuli including soluble or membrane-bound death ligands such as Fas-L. Apoptosis occurs in all cell types in the vessel wall and is implicated in the normal vasculature and disease conditions including arteriosclerosis, aortic aneurysms, arterial remodeling and medial degeneration [9] [10] [11] . Fas expressed on the cell surface predominantly determine the sensitivity of cells to its ligand, and specific stimuli such as p53 activation and interferon-c (IFN-c) treatment potentiate apoptosis by increasing cell surface Fas levels [12] [13] [14] . Many cell types including vascular cells retain the receptor in the Golgi compartment, thus rendering the cells more resistant to Fas-mediated apoptosis. Very little is known of the mechanisms by which, Fas is retained in the Golgi compartments of vascular cells. In this study we find that high levels of PP1201 can attenuate Fas surface expression and protects cells against Fas-Linduced apoptosis. Our results suggest that increased expression of PP1201 in response to shear stress could help to maintain vascular homeostasis by dampening the effects of Fas signaling.
Results
Exogenously expressed PP1201 protects against Fas-mediated apoptosis PP1201 contains two distinct segments, a 100 amino acidlong cytoplasmic region at the N-terminus and a putative seven-span transmembrane (TM) segment within a 211 amino acid-long C-terminus region (Fig. 1a) . NCBI blast search showed a high degree of similarity (53% identity at the amino acid level) between PP1201 and Fas apoptotic inhibitory molecule, LFG (Fig. 1b) mostly in the TM portions suggesting that PP1201 probably share the antiapoptotic function of LFG. To elucidate the possible mechanisms underlying impaired vascular homeostasis and the loss of smooth muscle cells in aged PP1201-deficient mice, we explored the role of PP1201 in cell death signaling pathways. The expression of PP1201 in human primary vascular cells and several tumor cell lines was evaluated by reverse transcriptase (RT)-PCR and Westernblot analyses. Cultured primary human umbilical vascular endothelial cells (HUVEC) and aortic smooth muscle cells (AoSMC) as well as human fibrosarcoma cell line (HT1080), human glioblastoma cell line (U251), human cervical cancer cell line (HeLa) expressed PP1201 at both mRNA and protein levels (Fig. 1c) . In contrast, human embryonic kidney cells (293-T) and Jurkat cells had very little mRNA and no protein. We chose Jurkat that expresses little protein and HT1080 cell line and AoSMC primary cells for further experimentation. Jurkat and HT1080 cells, known to be sensitive to Fas-mediated apoptosis, were infected with retroviruses carrying no cDNA (vector control), or cDNAs encoding PP1201. Cells transduced with green fluorescent protein (GFP)-expressing retrovirus in parallel to these transfection assays resulted in nearly 90% GFP-positive cells (data not shown). Pools of cells stably expressing the PP1201-cDNAs were selected and their expression at the protein level in both the cell lines was confirmed by Western blot analysis (Fig. 1d) .
As reported in case of LFG, stimulation with different amounts of Fas-L showed increased viability of PP1201 expressing both Jurkat and HT1080 cells compared with vector expressing control cells ( Fig. 2a and S1A) [5, 7, 8] . To examine whether the increased survival was the result of reduced cell death upon PP1201 expression, cells were stained with annexin-V and analyzed by flow cytometry. In agreement with the known ability of Fas-L to induce apoptosis in these cell lines, treatment with the ligand had resulted in an increase in the number of annexin-V positive cells in a time-dependent manner (Fig. 2b, c) . Annexin V-positive staining was more prominent in vector expressing control cells than PP1201 expressing Jurkat cells (24% vs. 13% in 4 h and 43% vs. 22% in 8 h) (Fig. 2b, c ) and HT1080 cells (26% vs. 13% in 6 h) ( Fig. S1B and C) . In addition, modest reduction in caspase-3 activation in PP1201 expressing cells was found indicating that ecotopic expression of PP1201 protects against FasL-induced caspase activation and apoptosis (Fig. 2d) . The resistance conferred by PP1201 against cell-death appears to be selective for Fas signaling as treatment with staurosporine (STS) or another death ligand, TNF-related apoptosis inducing ligand (TRAIL) showed only minimal to moderate effect on the cell viability (Fig. 2e, f) . Consistent with this, STS treatment also showed only marginal differences in annexin-V staining between vector and PP1201 expressing cells (54% vs. 43% in 6 h of STS stimulation) (Fig. 2b, c) . These results suggest that PP1201 is an antiapoptotic protein and protects against FasL-induced apoptosis. (Fig. 3a) . Because most of the homology between PP1201 and LFG is confined to their C-terminus TM regions, we tested whether the TM region mediates the interaction of PP1201 with the Fas. As expected, pull-down with anti-FLAG antibody from extracts of the cells expressing FLAG-Fas and V5-tagged PP1201 variant, PP1201 (103-311), precipitated PP1201 fragment without the cytoplasmic domain suggesting that the C-terminus segment containing the TM portion (Fig. 3b) . Attempts to express PP1201 without the TM (the cytosolic domain alone) detected little protein probably because of the rapid degradation of the expressed peptide (data not shown). In vascular cells, and other normal and cancer cell types the majority of Fas is sequestered in the Golgi apparatus [15] . Given that PP1201 associates with the Fas, we explored the possibility that PP1201 also localizes to the same compartment. It has been reported that PP1201 conjugated with enhanced green fluorescent protein (eGFP) at the Cterminus localizes to endosomal and lysosomal membrane compartments [2] . To determine the intracellular localization of endogenous PP1201, primary HUVEC cells were immunostained with anti-PP1201 antibody. Contrary to earlier reports confocal microscopic analysis revealed localization of PP1201 to mostly perinuclear compartments (Fig. 3c) .
Immunostaining with an antibody specific for GM130, a protein normally used as a marker to detect the Golgi compartment, showed a substantial colocalization between PP1201 and GM130-positive organelle. Further more, HeLa cells transiently expressing PP1201 conjugated with red fluorescent protein (RFP) at the cytosolic N-terminus, also resulted in the accumulation of PP1201 in the Golgi (Fig. 3d) . To explore whether Fas colocalizes with PP1201, we transfected HT1080 cells with Fas conjugated with CFP and RFP-PP1201 and found that both Fas and PP1201 colocalize to perinuclear compartments (Fig. 3e) (Fig. 4a, c) .
Western blot analysis of cellular extracts from both these cell types showed no changes in the total endogenous Fas pool level (Fig. 4b, d ) indicating that the reduced surface expression was not the result of altered Fas expression. These results collectively suggest that unlike LFG, PP1201 exerts its anti-apoptotic function by interfering with Fas protein trafficking that occurs between the Golgi and the plasma membrane. Because the TM region of PP1201 interacts with Fas, we explored whether this association could interfere with Fas cell surface expression. For this, we cotransfected HT1080 cells with eGFP plasmid along with PP1201 plasmid (either the full-length or the TM) and stained for surface Fas using APC-conjugated anti-Fas antibody. Analysis of cells positive for both eGFP and Fas showed reduced Fas expression in cells transfected with PP1201 full-length (MFI 630) or the TM (MFI 641) compared to vector-transfected cells (MFI 926) (Fig. 4e) .
Next we investigated whether PP1201 at constitutive level can regulate Fas trafficking, or the presence of high levels of the protein, which physiologically occurs in response to shear stress is required for its protective function. To address this, we used siRNA strategy to knockdown PP1201 expression in HT1080 that express basal levels of the protein, and in HT1080 cells that stably express PP1201. PP1201-specific siRNA was very effective in substantially reducing the protein in both cases (Fig. 5a, c) . Upon transfection with specifc siRNA in HT1080-PP1201 cells at 0.5 nM and 5.0 nM concentrations, the expression of PP1201 was reduced to varying degree (Fig. 5c ) and a corresponding increase in surface Fas in these cells was noted (Fig. 5d) . In cells transfected with 5.0nM specific siRNA PP1201 protein levels were reduced close to endogenous levels ( Fig. 5c ) and correspondingly, Fas on the surface of these cells increased and were found to be near to levels constitutively observed in HT1080. In HT1080 cells, loss of the basal PP1201 did not further increase Fas surface expression compared with nonspecific control siRNA transfected cells (Fig. 5b, d ). In agreement with these results, reduction in PP1201 had no (Fig. 5e) . These results collectively suggest that higher levels of PP1201 downregulate the expression of Fas on the surface and protect cells against FasL-induced apoptosis.
Discussion
Endothelial and smooth muscle cells that constitute the vascular system are constantly exposed to hemodynamic forces and a variety of biological substances including death ligands, cytokines, and cells present in blood. Several mechanisms intrinsic to the vessel wall offset the risk posed by these factors and play pivotal role in the maintenance of vascular homeostasis [16, 17] . These intrinsic mechanisms include the ability of vascular cells in response to shear stress to trigger changes in the activity or the expression of many proteins [18] [19] [20] [21] [22] [23] . PP1201 is one such shear stress responsive gene and mice deficient in PP1201 are prone to CMD [2] . The molecular mechanisms underlying the loss of SMC and the development of CMD in PP1201-null mice are largely unknown. The present study shows that PP1201 binds with the death receptor Fas, and protects against FasL-mediated death by reducing Fas expression on the plasma membrane. Several types of normal and cancer cells adopt downregulation of surface expression of Fas as a mechanism to attenuate Fas-mediated signaling. It has been reported that dynamin-2 and Fas-associated phosphatase 1 (FAP-1) regulate the export of Fas from the cytoplasm to the cell surface [24, 25] . Interferon c and hyperosmolarity are also reported to sensitize cells to apoptosis by triggering Fas membrane trafficking [26, 27] . Our findings suggest that PP1201-mediated reduction in Fas protein trafficking from the Golgi. Though the details of how PP1201 interfere with Fas surface expression are not clear, high levels of PP1201 could compete with molecules that facilitate Fas trafficking to the plasma membrane. Fas signaling are implicated in normal vascular development and in a variety of vascular pathologies [9] [10] [11] . Complex interactions between varieties of factors largely dictate whether apoptosis follows as a consequence of Fas signaling. For example, a DED-containing intracellular molecule the FLICE-like inhibitory protein (FLIP) associates with pro-apoptotic molecule caspase-8 at the DISC [14, 28, 29] . High levels of FLIP compete out caspase-8 at the activating complex and thus can block Fas-L-induced apoptosis. Other mechanisms that attenuate Fas signaling include expression of receptor molecules without the death domain (decoy receptors) such as DcR3 that compete with Fas for the death signal [30] . Another way cells resist Fas-L effect is by expressing low levels of Fas on the plasma membrane. Cell-cell interactions and mechanical hemodynamic forces in particular also play critical role in vascular cell apoptosis [9, 11] . Fluid shear stress reduces apoptosis, and higher rates of cell death were reported at areas of low shear [31] . Cells in response to fluid force upregulate the expression of many molecules, some of which are believed to be anti-apoptotic in function [1, 16, 17] . PP1201 is one such shear stress responsive gene product and our findings suggest that it can protect cells against Fas-L-induced apoptosis. PP1201 belongs to an evolutionarily conserved family of anti-apoptotic proteins with different tissue expression profiles and sub-cellular localizations. Our data suggest that the protective role of PP1201 is limited to cells with high levels of protein, such as vascular cells in which its expression is upregulated in response to hemodynamic forces.
Contrary to our finding that PP1201 mostly associates with the Golgi, Zhao et al., reported that PP1201 localizes to lysosomal and endosomal vesicles [2] . For localization assays Zhao et al. used a PP1201 construct in which GFP was conjugated to the TM. Because the TM targets the protein to the membrane, to avoid potential interference of GFP with the protein localization we used specific anti-PP1201 antibody to immunostain endogenous PP1201. Consisting with the association of endogenous PP1201 with the Golgi, a PP1201 construct that expresses the TG as free domain with the RFP conjugated at the cytosolic domain also accumulated in the GM130
? compartments. Engagement of Fas with Fas-L also triggers several biological responses such as cell proliferation, chemokine production unrelated to apoptosis [32] [33] [34] [35] . Treatment of primary endothelial cells with FasL is known to activate extracellular signal regulated kinase-1 and -2 (Erk1/2), and to induce matrix metalloproteinase (MMP)-9 and probably MMP-2 activity [36, 37] . Both MMP-9 and MMP-2 belong to the gelatinase group of MMPs that play important role in cardio-vascular remodeling [38] . It is possible that suppression of Fas signaling by PP1201 could also negatively affect MMP production. Interestingly, the reported elevation of MMP-2 and MMP-9 activities in PP1201-deficient CMD mice supports such a notion [3] . Thus, enhanced non-apoptotic Fas signaling in PP1201-deficient mice might also contribute to the development of aneurysm.
Materials and methods

Cell lines and primary cells
Jurkat cells (clone E6-1) were maintained in RPMI media supplemented with 10% FBS (Fetal Bovine Serum). 293 cells and human fibrosarcoma cell line HT1080 were maintained in DMEM media supplemented with 10% FBS. AoSMC (Aortic Smooth Muscle Cells, Catalog No. CC-2571) and HUVEC (Human Umblical Vein Endothelial Cells, Catalog No. CC-2517) were purchased from Lonza and were cultured and maintained in prescribed media SmGM-2 (Lonza, Catalog No. CC-3182) and EGM-2 (Lonza, Catalog No. CC-3162), respectively. All the cells were kept in incubator at 37°C in the presence of 5% CO 2 .
RNA extraction and RT-PCR analysis
Actively growing cells were lysed in Trizol reagent from Invitrogen Corporation (Carlsbad, CA) following which; RNA was purified from the aqueous phase, after addition of 0.2 volumes choloform, using RNeasy Mini kit from Qiagen (Valencia, CA). Equal amount of total RNA from each sample was subjected to reverse transcription with oligo dT primers in a 20 ll reaction using the Superscript III cDNA synthesis system, Invitrogen Corporation (Carlsbad, CA). Polymerase Chain Reaction was performed for 22 cycles using equal volume of each first strand reaction mix (3 ll) as template for PCR with PP1201 (F: 5 0 -CACCGGATC CATGTCCAACCCCAGCGCCCC-3 0 , R: 5 0 -ATCGCGCG GCCGCTTAATTGCGATCCCCCATCAG-3 0 ) and GAP-DH (F: 5 0 -CTGACCTGCCGTCTAGAAA-3 0 , R: 5 0 -TTT CTAGACGGCAGGTCAG-3 0 ) primers in a 50ul PCR reaction in (GeneAmp PCR Amplification System 9700, Applied Biosystems) thermo cycler.
Generation of stable cell lines
Jurkat and HT1080 stable cell lines expressing PP1201 and LFG were generated through retroviral transfection and after selection on puromycin. To produce virus 1.8 9 10 6 293 cells were plated 1 day before of transfection. On next day 3 lg of either pMY-IP (Puromycin marker) or pMY-PP1201 or pMY-LFG were taken along with 3 lg of each pVpack-VSV-G and pVpack-GP (Stratagene) and were tansfected using Lipofectamin 2000 (Invitrogen). Media was substituted with 3 ml fresh media after 6 h. After 48 h media was collected and 1 ml of it was added on 0.1 million of desired cell line. After 24 h 1 ml of fresh media was added in cells and again kept for 24 h. As a control to assess the infection efficiency of virus, GFP containing virus was also used. After 48 h of FACS analysis was performed to check infection efficiency. After that cells were harvested and selected and maintained in the presence of 2 lg/ml of puromycin. 
Cell viability assay
Cell viability assay was done using cell counting kit 8 (Catalog No. CK04-13, Dojindo)
According to manufacturer's protocol. Briefly, 1 9 10 4 either Jurkat cells or 0.5 9 10 4 HT1080 cells (1 day before treatment) were seeded in 96 well plate. Jurkat cells were treated with increasing concentrations of Fas-L to induce apoptosis. Untreated cells were considered as growth control and only media as background. In the case of HT1080 apoptosis was induced by treating cells 20 ng/ml Fas-L along with 0.5 lg/ml cycloheximide to block protein synthesis. Cells treated with cycloheximide only were considered as growth control. Cells were kept in incubator at 37°C for 24 h and on next day 10 ll of Dojindo's cell counting kit reagent was added in each sample and after mixing plate was kept in incubator for 2-4 h or until color develops. Absorbance was measured at 450 nm.
FACS analysis
Detection of surface expression of endogenous Fas
Staining of surface Fas was done by using anti-Fas-PE Ab (BD Pharmingen) according to manufacture's protocol. Briefly 1.0 million cells were taken and washed with 1 ml chilled FACS buffer (1XPBS ? 2% FBS) and then finally resuspended into 80 ll FACS buffer. 20 ll of anti-Fas-PE Ab were added to samples. As a control staining was done with 20 ll of non-specific mouse IgG conjugated with PE. Samples were kept on ice for 45 min and then washed twice with FACS buffer and immediately analyzed by flow cytometry (FACS Calibur flow cytometer Becton-Dickinson). In the case of transient transfection with HT1080 and AoSMCs, expression plasmid 5 lg of either pCDNA3 PP1201 or pCDNA3 PP1201-TM (expressing transmembrane region amino acid 103-311) transfected along with 1 lg of peGFP (clonetech). 48 h post transfection cells were harvested and staining for Fas was done using antibody conjugated with APC. Ten thousand cells were acquired and double positive cells were analyzed for the surface expression of Fas.
Apoptosis assay using Annexin-V and PI Apoptosis was measured by using Annexin V-FITC Apoptosis Detection Kit-1 (BD Pharmingen) according to manufacturer's protocol. For induction of apoptosis 1 million Jurkat cells were treated with either 20 ng/ml Fas-L (R&D systems, Catalog No. 126-FL) or 0.5 lM staurosporine and kept in incubator at 37°C for different periods and untreated cells were considered as control. In the case of HT1080, 0.5 million cells were seeded 1 day before treatment. On the day of treatment cells were either treated with 1 lg/ml cycloheximide or in combination with 20 ng/ ml Fas-L to induce apoptosis and kept in incubator for desired period. Cells treated with only cycloheximide were considered as control. On completion of treatment cells were washed twice with cold PBS then resuspended in 19 Annexin V binding buffer (supplied with kit) at concentration of 1 9 10 6 cells/ml. 100 ll of this solution was taken into a 5 ml culture tube and 5 ll of Annexin V-FITC and 5 ll of Propidium Iodide (PI) were added and after mixing sample was kept for 15 min at RT in dark. 400 ll of 19 Annexin V binding buffer was added to this solution and analyzed immediately by flow cytometry.
Caspase activity Caspase-3 activity was measured by using EnzChek Caspase-3 Kit (Molecular Probes, Catalog No. MP-13183) according to manufacturer's protocol. Briefly, 2.0 million Jurkat cells were treated with 20 ng/ml Fas-L to induce apoptosis and kept in incubator for desired length of time. Cells were left untreated as a negative control. Upon completion of treatment cells were washed twice with cold PBS and then lysed with the addition of 19 Cell lysis buffer (supplied with kit) and kept on ice for 30 min. After completion of lysis supernatants were taken and apoptosis were assayed as described in detail product literature. As an additional control Ac-DEVD-CHO inhibitor was added to the 6 h Fas induced sample to rule out any artifactual measurement of the enzymatic activity.
Western blot and coimmunoprecipitation
For coimmunoprecipitation 1.8 9 10
6 293 cells were seeded 1 day before transfection. On the day of transfection 6.0 lg pCDNA3 FLAG-Fas (N terminal FLAG tagged human Fas) expression plasmid and 2.0 lg pCDNA3 PP1201 expression plasmid or pCDNA3 nV5 PP1201-TM (N terminal V5 tagged truncated PP1201 expressing aa 103-311 containing transmembrane region) were transfected alone or in combination using Lipofectamine 2000 (Invitrogen). After transfection cells were kept in incubator for 48 h. After that cells were harvested and washed once with cold PBS then resuspended into 500 ll of 19 cell lysis buffer (Cell Signaling Technology, Catalog No. 9803) and kept on ice for 45 min for lysis to occur. Samples were spun at 13000 RPM for 15 min at 4°C. Small aliquots of these samples were taken and saved for detection of expression levels of transfected expression plasmids. Supernatant was collected and 2 lg non-specific mouse IgG1 (Catalog No. 557273, BD Pharmingen) was added and kept on rotation at 4°C for 30 min. Mean while Protein-G Sepharose beads were equilibrated with PBS followed by 19 cell lysis buffer. 50 ll of equilibrated beads were added to each samples and kept on rotation for another 30 min at 4°C. Samples were spun at 3000 RPM for 1 min and supernatant was collected and 2 lg mouse Anti FLAG M2 (Catalog No. F3165, Sigma) was added to sample and kept on rotation for 4 h at 4°C. After that 50 ll equilibrated beads were added to sample and kept on rotation for another 2 h. Upon completion of rotation samples were spun at 3000 RPM for 1 min and beads were collected and washed thrice with 19 cell lysis buffer. 50 ll of 29 SDS loading dye was added to washed beads and kept at 37°C for 30 min with intermittent vortexing. Supernatant of these samples were loaded on SDS-PAGE and after transfer to PVDF membranes, immunoblotting was done with anti PP1201 Ab or anti V5 Ab. Expression of proteins was also checked in lysates.
Immunostaining and colocalization
Immunostaining was performed according to protocol described previously (46). For colocalization study HT1080 cells were cotransfected with expression plasmids 2.0 lg Cyan Fluorescent Protein (CFP)-Fas and 2.0 lg Red Fluorescent Proten (RFP) PP1201 using Lipofectamin 2000. After 24 h of transfection picture was captured using a Zeiss LSM 510 confocal system using 63X1.4NA PlanApochromat oil immersion objective.
Silencing of PP1201 by siRNA
To silence the expression of PP1201 0.5 million desired cell line or primary cells were seeded 1 day before transfection. On the day of transfection 50 nM ON-Target plus SMART pool (Thermo Scientific Dharmacon RNAi Technologies,Catalog No. L-015095-01) specific to human PP1201 was transfected using Lipofectamine RNAiMAX (Invitrogen) and kept for 24 h, 48 h and 72 h. As controls nontargeting siRNA were also transfected separately along with specific knocking down. Cells were harvested after completion of treatment, cells were lysed in 19 Cell Lysis Buffer (Cell Signaling Technology, Catalog No. 9803) and samples were spun at 13000 RPM for 15 min at 4°C. Supernatants were taken and run on SDS-PAGE then immunoblotted with
